Ultrasound engine heads for RSNA show

Article

Analogic will introduce its AN2300 Digital Ultrasound Engine on the RSNA exhibit floor. The company’s digital engine provides the hardware and real-time software necessary to acquire, process, and convert ultrasound echo information into a video

Analogic will introduce its AN2300 Digital Ultrasound Engine on the RSNA exhibit floor. The company’s digital engine provides the hardware and real-time software necessary to acquire, process, and convert ultrasound echo information into a video display. It can support clinical applications in cardiology, general radiology, breast, and small parts imaging. This PC-based subsystem, designed for sale to OEMs, is intended to cost-effectively address the imaging needs of specific applications or even niche markets that otherwise might not justify the development of an imaging platform. A complete turnkey system can be created quickly by adding transducers, a unique user interface, ergonomic packaging, clinical software application, and a display. AN2300’s linear waveform transmit and receive beamformers use Analogic’s second-generation ASIC and broadband spline interpolation filter, capable of synthesizing up to 256 receive channels. Advanced imaging modes include parallel beam processing, harmonic receive of up to 15 MHz, beam steering, spectral Doppler, color-flow or power modes, and line-interleaved duplex or triplex combination modes. Complementing the engine is an open software interface that allows developers to program the system using a high-level programming language under Windows NT. An in-depth knowledge of the detailed engine hardware is not required.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
New Mammography Research Examines Impact of High-Resolution DBT
Can Radioligand Therapy Have an Impact for Women with Breast Cancer?
Emerging Concepts in CT-Guided Treatment of Coronary Artery Disease
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.